AI Science Tracker
EN

Machine-learning models identify prostate-cancer diagnostic and metastasis-associated biomarkers

Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, China · 25 Jun 2024 · medicine

Discovery

Machine-learning models identify prostate-cancer diagnostic and metastasis-associated biomarkers

Source check: Source checked. Not independent scientific confirmation.

Finding: Expression-dataset analyses produced prostate-cancer diagnostic and metastasis-related models and prioritized POLD1 for further assessment. Separate GEO datasets and a tissue microarray provided follow-up evidence; computational drug-response predictions are not experimental treatment evidence.

Technology: Machine-learning classifiers and a LASSO model built diagnostic and metastasis-risk predictions from expression-derived features.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Machine-learning classifiers and a LASSO model built diagnostic and metastasis-risk predictions from expression-derived features.
Test and result
The models were assessed on GEO datasets; tissue-microarray immunohistochemistry provided follow-up for POLD1 expression.
Limitation / still unknown
Predictive and biomarker evidence does not establish a biological mechanism or treatment efficacy; drug-response analyses remain computational.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s13062-024-00494-x

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary full-text review as recorded in case evidence; record-level claim and attribution review..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.